1-10 of 10
Raymond S Wong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Pegcetacoplan Treatment in Complement-Inhibitor Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Phase 3 Prince Study

Raymond S Wong, Juan Ramon Navarro, Narcisa Sonia Comia, Yeow Tee Goh, Henry Idrobo, Daolada Kongkabpan, David Gomez-Almaguer, Mohammed Al-Adhami, Temitayo Ajayi, Paulo Alvarenga, Pascal Deschatelets, Cedric Francois, Federico Grossi, Teresita Dumagay
Journal: Blood
Blood (2021) 138 (Supplement 1): 606.
https://doi.org/10.1182/blood-2021-147493
Published: 2021
Journal Articles

Categorized Hematologic Response to Pegcetacoplan and Correlations with Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria: Post Hoc Analysis of Data from Phase 1b, Phase 2a, and Phase 3 Trials

Antonio Risitano, Raymond S Wong, Mohammed Al-Adhami, Crystal Chen, Regis Peffault De Latour
Journal: Blood
Blood (2021) 138 (Supplement 1): 1104.
https://doi.org/10.1182/blood-2021-147988
Published: 2021
Journal Articles

Post Hoc Analysis of the Effect of Pegcetacoplan Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria and Baseline Hemoglobin Levels Greater Than 10 Grams per Deciliter

Jens Panse, Nicolas Daguindau, Sonia Okuyama Sasaki, Regis Peffault De Latour, Philippe Schafhausen, Nicole Straetmans, Mohammed Al-Adhami, Temitayo Ajayi, Crystal Chen, Michael Yeh, Raymond S Wong
Journal: Blood
Blood (2021) 138 (Supplement 1): 2194.
https://doi.org/10.1182/blood-2021-146962
Published: 2021
Journal Articles

C3 Inhibition with Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Paddock and Palomino Trials

Raymond S Wong, MBChB, MD, Kalina Ignatova, Humphrey Pullon, Jameela Sathar, Pimjai Niparuck, MD, Tontanai Numbenjapon, Eric Tse, MBBS, PhD FRCP, FRCPath, Surapol Issaragrisil, MD, Eloy Roman, MD, Ismail Amine, Lisa Tan, Carl Di Casoli, Pascal Deschatelets, PhD, Cedric Francois, MD PhD, Federico Grossi, MD, Andrija Bogdanovic
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-134436
Published: 2020
Journal Articles

Myeloproliferative Neoplasms in Asia, Including Middle East, Turkey, and Algeria: Epidemiological Indices and Treatment Practice Patterns from the Multinational, Multicenter, Observational MERGE Registry

Mohamed A Yassin, Ali Taher, MD PhD, Vikram Mathews, MD, Hsin-An Hou, MD PhD, Tahir Shamsi, Tulin Tuglular, MD, Zhijian Xiao, Soo-Jeong Kim, MD, Depei Wu, MD PhD, Junmin Li, MD, Gerd Rippin, Islam Sadek, Asif Siddiqui, PhD, Raymond S Wong, MBChB, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5461.
https://doi.org/10.1182/blood-2018-99-114416
Published: 2018
Journal Articles

Impact of Myeloproliferative Neoplasms (MPNs) on Health-Related Quality of Life (HRQOL) and Medical Resource Utilization: Results from the MERGE Registry

Ali Taher, MD PhD, Mohamed A Yassin, Zhijian Xiao, Hsin-An Hou, MD PhD, Tulin Tuglular, MD, Vikram Mathews, MD, Gerd Rippin, Islam Sadek, Asif Siddiqui, PhD, Raymond S Wong, MBChB, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4311.
https://doi.org/10.1182/blood-2018-99-113248
Published: 2018
Journal Articles

Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag (EPAG) in Patients Who Did and Did Not Receive Prior Rituximab (Ritux): A Post-Hoc Analysis of the Extend Study

Oliver Meyer, James B. Bussel, MD, Raymond S Wong, MBChB, MD, Abderrahim Khelif, Miona Stankovic, Joan Maier, Mansoor N. Saleh
Journal: Blood
Blood (2018) 132 (Supplement 1): 1152.
https://doi.org/10.1182/blood-2018-99-114694
Published: 2018
Journal Articles

Superior Restoration of Health with Siltuximab Among Multicentric Castleman’s Disease Patients When Measured By SF-36

Frits van Rhee, MD PhD, Corey Casper, MD, Margaret K Vernon, PhD, Dylan Trundell, MSc, Don Robinson, MSPH, Jianming He, PhD, Jessica Vermeulen, MD PhD, Helgi van de Velde, MD PhD, Raymond S Wong, MD
Journal: Blood
Blood (2014) 124 (21): 4469.
https://doi.org/10.1182/blood.V124.21.4469.4469
Published: 2014
Journal Articles

Vemurafenib As First Treatment of Hairy Cell Leukemia

Gregory Cheng, Gym Cheng, MDPhD, Natalie Pui Ha Chan, Chris Wong, Raymond S Wong, MD
Journal: Blood
Blood (2014) 124 (21): 5482.
https://doi.org/10.1182/blood.V124.21.5482.5482
Published: 2014
Journal Articles

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy and Safety Of Siltuximab, An Anti-Interleukin-6 Monoclonal Antibody, In Patients With Multicentric Castleman’s Disease

Raymond S Wong, Corey Casper, Nikhil Munshi, Xiaoyan Ke, Alexander Fosså, David Simpson, Marcelo Capra, Ting Liu, MD, Ruey Kuen Hsieh, Yeow Tee Goh, Jun Zhu, Seok-Goo Cho, Hanyun Ren, James Cavet, Rajesh Bandekar, Margaret Rothman, Thomas A Puchalski, Shalini Chaturvedi, Helgi van de Velde, Jessica Vermeulen, Frits van Rhee
Journal: Blood
Blood (2013) 122 (21): 505.
https://doi.org/10.1182/blood.V122.21.505.505
Published: 2013